STOCK TITAN
  1. Home
  2. Sec-filings
  3. AVAH
  4. [Form 4] Aveanna Healthcare Holdings, Inc. Insider Trading Activity

Aveanna Healthcare (AVAH) CCO sells 125K shares in open-market trade

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Aveanna Healthcare Holdings, Inc. Chief Compliance Officer Patrick A. Cunningham reported an open-market sale of 125,000 shares of common stock at a weighted average price of $7.5883 per share. The sale occurred on May 20, 2026 and reflects a discretionary transaction in the market.

Following this sale, Cunningham directly holds 212,755 shares of Aveanna common stock. The reported price range for the trades was between $7.50 and $7.69 per share, based on multiple individual transactions combined into the disclosed weighted average price.

Positive

  • None.

Negative

  • None.
Insider Cunningham Patrick A.
Role Chief Compliance Officer
Sold 125,000 shs ($949K)
Type Security Shares Price Value
Sale Common Stock, par value $0.01 per share 125,000 $7.5883 $949K
Holdings After Transaction: Common Stock, par value $0.01 per share — 212,755 shares (Direct)
Footnotes (1)
  1. F1. The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.50 to $7.69. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Shares sold 125,000 shares Open-market sale on May 20, 2026
Weighted average sale price $7.5883 per share Common stock, par value $0.01
Price range $7.50–$7.69 per share Range of individual sale transactions
Shares held after transaction 212,755 shares Direct ownership following sale
Transaction date May 20, 2026 Date of open-market sale
open-market sale financial
"reported an open-market sale of 125,000 shares of common stock"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
weighted average sale price financial
"The price is the weighted average sale price for the transactions"
Form 4 regulatory
"The transaction was disclosed on a Form 4 and reflects a discretionary sale"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
Chief Compliance Officer financial
"Chief Compliance Officer Patrick A. Cunningham reported an open-market sale"
The chief compliance officer is the senior executive responsible for making sure a company follows laws, industry rules and its own internal policies, acting like a safety inspector for legal and ethical risks. Investors care because effective compliance reduces the chance of fines, lawsuits, operational disruption and reputational damage, so the officer’s competence and independence can materially affect future profits and risk exposure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider transaction did Aveanna Healthcare (AVAH) report for Patrick A. Cunningham?
Aveanna Healthcare reported that Chief Compliance Officer Patrick A. Cunningham executed an open-market sale of 125,000 common shares. The transaction was disclosed on a Form 4 and reflects a discretionary sale of existing holdings rather than an option exercise or grant.

How many Aveanna Healthcare (AVAH) shares does Patrick A. Cunningham hold after the sale?
After the reported transaction, Patrick A. Cunningham directly holds 212,755 shares of Aveanna common stock. This figure appears in the Form 4 as the total shares owned following the sale, giving investors context on his remaining personal equity stake.

At what price did Patrick A. Cunningham sell Aveanna Healthcare (AVAH) shares?
The reported weighted average sale price was $7.5883 per share for the 125,000 Aveanna shares sold. A footnote explains that individual trades occurred between $7.50 and $7.69, and full price-by-price details are available upon request from the reporting person.

Was the Aveanna Healthcare (AVAH) insider transaction an open-market sale?
Yes. The Form 4 describes Patrick A. Cunningham’s transaction as an open-market sale of common stock. This means the shares were sold through normal trading channels, rather than being granted, exercised from options, or transferred as part of a non-market restructuring.

Does the Aveanna Healthcare (AVAH) filing mention any option exercises or derivatives for this insider?
No derivative transactions are listed in this Form 4. The filing’s derivative summary is empty, and the only reported activity is the non-derivative open-market sale of 125,000 common shares, simplifying interpretation of the insider’s equity position after the trade.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cunningham Patrick A.
(Last)(First)(Middle)
C/O AVEANNA HEALTHCARE HOLDINGS INC.
400 INTERSTATE NORTH PARKWAY SE
(Street)
ATLANTA GEORGIA 30339
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Aveanna Healthcare Holdings, Inc. [ AVAH ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Compliance Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock, par value $0.01 per share05/20/2026S125,000D$7.5883(1)212,755D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.50 to $7.69. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ Jonathan Beckler, Attorney-in-Fact05/21/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR